1. Risk behavior and HIV seroincidence in the US trial of AIDSVAX B/B;Bartholow;AIDS Vaccine,2003
2. HIV vaccine development;Berman,2003
3. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies and imperfect vaccines;Blower;AIDS,2003
4. Declines in risk behaviour are smaller in phase III vaccine trial participants that in non-vaccine trial control group;Buchbinder;AIDS Vaccine,2003
5. Public health considerations for the use of a first generation HIV vaccine. Report from a WHO-UNAIDS-CDC consultation, Geneva, 20–21 November 2002;Chang;AIDS,2003